体重和血糖变化可独立于β细胞功能改善而预防早期糖尿病进展
该研究为早期糖尿病干预计划(EDIP)的二次分析,EDIP是一项随机、安慰剂对照试验,纳入219例空腹血糖<7.8 mmol/L且口服葡萄糖耐量试验2小时血糖>11.1 mmol/L的超重个体,比较阿卡波糖与安慰剂并辅以饮食建议,随访至多5年。结果显示无进展状态与体重、空腹血糖、2小时OGTT血糖下降及高密度脂蛋白/甘油三酯比值升高相关,多变量Cox模型中仅空腹血糖下降与无进展状态独立相关,而空腹血糖下降主要与体重和2小时OGTT血糖下降相关,阿卡波糖治疗不能解释这些变化。结论认为早期糖尿病中由体重下降驱动的血糖降低可延缓代谢恶化。
要点
- 早期糖尿病患者中,体重下降驱动的空腹血糖降低与无进展状态独立相关。
- 阿卡波糖治疗不能解释体重、空腹血糖及2小时OGTT血糖的变化。
- 生活方式管理包括减重可能有助于缓解新诊断糖尿病的血糖恶化。
核心结论
- 在早期糖尿病中,由体重下降驱动的血糖降低可延缓代谢进展性恶化,这些观察强调生活方式管理包括减重作为缓解新诊断糖尿病血糖恶化的工具的重要性。
研究设计与样本
- EDIP为随机、安慰剂对照试验,在两家大学糖尿病中心进行,共纳入219例空腹血糖<7.8 mmol/L且2小时OGTT血糖>11.1 mmol/L的超重个体。
- 干预为阿卡波糖对比安慰剂,背景为饮食建议,每季度访视评估血糖和干预依从性,随访至多5年。
- 主要结局为连续两次季度访视空腹血糖≥7.8 mmol/L的进展;采用Cox比例风险模型和方差分析评估进展决定因素。
主要发现
- 无进展状态与体重、空腹血糖、2小时OGTT血糖下降及高密度脂蛋白/甘油三酯比值升高相关。
- 多变量Cox模型中,空腹血糖下降是唯一仍与无进展状态显著相关的效应。
- 空腹血糖下降主要与体重和2小时OGTT血糖下降相关。
- 阿卡波糖治疗不能解释这些变化。
临床怎么用
- 作者认为,在新诊断糖尿病中,生活方式管理包括减重可作为缓解血糖恶化的工具。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Evidence-based strategies to prevent progression of dysglycemia in newly diagnosed type 2 diabetes are needed. OBJECTIVE: To undertake a secondary analysis of the Early Diabetes Intervention Program (EDIP) in order to understand the features that were protective against worsening glycemia. DESIGN: EDIP was a randomized, placebo-controlled trial. SETTING: Two university diabetes centers. PATIENTS: A total of 219 overweight individuals with fasting glucose < 7.8 mmol/L and 2-hour oral glucose tolerance test (OGTT) glucose > 11.1 mmol/L. INTERVENTIONS: Acarbose versus placebo, on a background of dietary recommendations, with quarterly visits to assess glycemia and intervention adherence for up to 5 years. MAIN OUTCOME MEASURES: Progression of fasting glucose ≥ 7.8 mmol/L on two consecutive quarterly visits. Cox proportional hazards modeling and ANOVA were performed to evaluate determinants of progression. RESULTS: Progression-free status was associated with reductions in weight, fasting glucose, 2-hour OGTT glucose, and increases in the high-density lipoprotein/triglyceride ratio. The reduction in fasting glucose was the only effect that remained significantly associated with progression-free status in multivariable Cox modeling. The reduction in fasting glucose was in turn primarily associated with reductions in weight and in 2-hour OGTT glucose. Acarbose treatment did not explain these changes. CONCLUSIONS: In early diabetes, reductions in glucose, driven by reductions in weight, can delay progressive metabolic worsening. These observations underscore the importance of lifestyle management including weight loss as a tool to mitigate worsening of glycemia in newly diagnosed diabetes.
引用
- Patel YR, Kirkman MS, Considine RV, et al. Changes in Weight and Glucose Can Protect Against Progression in Early Diabetes Independent of Improvements in β-Cell Function. J Clin Endocrinol Metab. 2016. PMID: 27533307
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。